Bladder Cancer - Results from #500

REVIEW UroToday

A Prognostic Index Derived From LASSO-Selected Preoperative Inflammation and Nutritional Markers for Non-Muscle-Invasive Bladder Cancer. March 26, 2024

Racial Differences in the Detection Rate of Bladder Cancer Using Blue Light Cystoscopy: Insights from a Multicenter Registry March 25, 2024

Longitudinal Tumor-informed Circulating Tumor DNA Status Predicts Disease Upstaging and Poor Prognosis for Patients Undergoing Radical Cystectomy. March 25, 2024

Identifying the supportive care needs of people affected by non-muscle invasive bladder cancer: An integrative systematic review. March 25, 2024

Determining the clinicopathological significance of the VI-RADS ≧4 group: a retrospective study. March 22, 2024

The effect of race/ethnicity on cancer-specific mortality after trimodal therapy. March 22, 2024

A Genomic Urine Assay for Surveillance of Patients with Bladder Cancer Treated with Radiotherapy. March 21, 2024

Performance of VI-RADS in predicting muscle-invasive bladder cancer after transurethral resection: a single center retrospective analysis. March 21, 2024

The impact of perioperative risk factors on long-term survival after radical cystectomy: a prospective, high-volume cohort study. March 20, 2024

Patterns of treatment of high-risk BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) patients among Arab urologists. March 20, 2024

Why Does the Incidence of NMIBC Rise with Age? - Expert Commentary March 19, 2024

Cost-effectiveness analysis of different treatment modalities in BCG-unresponsive NMIBC. March 19, 2024

Trimodal therapy effect on survival in urothelial vs non-urothelial bladder cancer. March 19, 2024

Photocure Partner Asieris Announces Positive International Phase III Clinical Trial Results for Cevira and Data Presentations at the 2024 EUROGIN Congress and SGO Annual Meeting March 18, 2024

Addition of neoadjuvant chemotherapy to a 'quadrifecta' composite in radical cystectomy. March 18, 2024

"I think my vagina is still there?": Women's perspectives on sexual function and dysfunction following radical cystectomy for bladder cancer, a qualitative study. March 18, 2024

AIM High: Epigenetic Modulation and Immune Stimulation in Bladder Cancer March 15, 2024

Characterization of Targets for Antibody-Drug Conjugates in Advanced Urothelial Carcinoma - Expert Commentary March 15, 2024

Alignment of molecular subtypes across multiple bladder cancer subtyping classifiers. March 15, 2024

Efficacy of cytoreductive radical cystectomy in metastatic urothelial bladder cancer based on site and number of metastases. March 15, 2024

Page 26 of 517